×

img Acces sibility Controls

Research Projects Banner

Research Projects

Novel beta3-adrenergic agonists as senolytics and insulin sensitizers: studies in adipose tissue of metabolic dyshomeostasis model systems

Implementing Organization

Principal Investigator
Dr. Anil Nilkanth Gaikwad
CsIR-Central Drug Research Institute, Lucknow, Uttar Pradesh
CO-Principal Investigator
Dr. sashidhara V Koneni
CsIR-Central Drug Research Institute, Lucknow, Uttar Pradesh

Project Overview

India has become the world's diabetic hub, with 74.2 million patients and expected to reach 124.8 million by 2045. Diabetes and obesity are emerging global health challenges, with metabolic disorders linked to chronic low-grade inflammation. Adipose tissue plays a crucial role in glucose, lipid, and energy homeostasis. Aging is correlated with increased prevalence of diabetes, cardiovascular diseases, and dyslipidemia. Adipose tissue senescence is a major contributor to obesity and age-associated metabolic disorders. The research aims to develop and characterize a chronic hyper-insulinemia induced insulin resistance model in 3T3-L1 and hMsC derived adipocytes and their effects on senescence pathways in in vivo tissue levels. Elevated glucose and lipid levels cause inflammation and accumulation of senescent cells in adipose tissue. Increasing healthy lifespan can decrease adipose senescence. beta3 adrenergic receptor agonists are proposed as potential senolytics to eliminate senescent cells. This project will open new avenues for generating therapies for age-associated metabolic disorders.
Funding Organization
Funding Organization
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Endocrinology, diabetology, metabolomics
Start Year
2024
End Year
2027
Sanction Amount
₹ 49.84 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop